Concepedia

Eslie Dennis

ED

Statistics

Publications

10

Citations

1.1K

H-Index

10

Active since

2003

Affiliations

Ventana Research Corporation (United States)(Current)

Mayo Clinic

Tris Pharma (United States)

Novartis (Switzerland)

Mayo Clinic in Arizona

Eslie Dennis is an author at Ventana Research Corporation (United States) specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2003–2021

10

Publications

10

Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact

A. P. S. Hungin, Lin Chang, G. Richard Locke et al. · Alimentary Pharmacology & Therapeutics · 2005 · 491 citations · Full text

, , +13

Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea

Nicholas J. Talley, Eslie Dennis, Virginia A. Schettler-Duncan et al. · The American Journal of Gastroenterology · 2003 · 240 citations

, , +13

Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab

Bharathi Vennapusa, Brian M. Baker, Marcin Kowanetz et al. · Applied immunohistochemistry & molecular morphology · 2018 · 189 citations · Full text

, , +17

Activation of peripheral 5‐HT<sub>4</sub>receptors attenuates colonic sensitivity to intraluminal distension

B. Greenwood-Van Meerveld, Kalina Venkova, Gareth A. Hicks et al. · Neurogastroenterology & Motility · 2005 · 58 citations · Full text

, , +17

HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients

Sasagu Kurozumi, Mary Padilla, Masafumi Kurosumi et al. · Breast Cancer Research and Treatment · 2016 · 48 citations · Full text

, , +15

1–5 of 10